Vascular Remodeling, Oxidative Stress, and Disrupted PPARγExpression in Rats of Long-Term Hyperhomocysteinemia with Metabolic Disturbance

Yajing Huo, Xuqing Wu, Jing Ding, Geng Yang, Weiwei Qiao, Anyan Ge, Cen Guo, Jianing Lv, Haifeng Bao, Wei FanPPAR 2018 · DOI

TL;DR

This study investigates how long-term high homocysteine levels, combined with metabolic disturbances, contribute to vascular remodeling in rats. The research highlights that this condition leads to impaired oxidative stress defense, reduced nitric oxide availability, and a significant decrease in PPARγ expression in coronary arterioles, suggesting these factors are key drivers of vascular damage.

What Problem Does This Paper Address?

Hyperhomocysteinemia (Hcy), an elevated level of homocysteine in the blood, is a well-established risk factor for vascular diseases like atherosclerosis. It's also increasingly recognized as a potential component of metabolic syndrome. While previous research has linked Hcy to vascular remodeling and oxidative stress, the precise mechanisms, especially in the context of long-term exposure and co-occurring metabolic issues, remain unclear. This paper aims to bridge this gap by exploring how chronic hyperhomocysteinemia, induced by a methionine-rich diet in rats, affects vascular remodeling, oxidative stress markers, and the expression of PPARγ, a nuclear receptor known to play a role in vascular health and metabolism. Understanding these mechanisms is crucial for developing targeted therapeutic strategies for individuals with both hyperhomocysteinemia and metabolic disturbances.

Methods

The researchers employed a rat model to simulate long-term hyperhomocysteinemia. Wistar rats were fed either a standard rodent chow (Control group) or a diet enriched with methionine (Met group) for 48 weeks. This extended duration was chosen to mimic chronic exposure.

Key measurements and analyses included:

  • Biochemical Assays: Plasma homocysteine, fasting blood glucose, serum lipids (triglycerides, total cholesterol, HDL, LDL), malondialdehyde (MDA) as a marker of lipid peroxidation, superoxide dismutase (SOD) activity as an antioxidant defense marker, and nitric oxide (NO) levels.
  • Oral Glucose Tolerance Test (OGTT): To assess glucose metabolism and insulin sensitivity.
  • Histomorphometric Analysis: Coronary arterioles and carotid arteries were examined histologically using H&E and Masson's trichrome staining to assess vascular wall thickening, collagen deposition, and wall-to-lumen ratios, providing quantitative measures of vascular remodeling.
  • Immunohistochemistry: This technique was used to specifically detect and quantify the expression of PPARγ in the coronary arterioles, identifying its cellular localization and changes in expression levels.

Datasets

Not discussed in the paper. The study utilized a rat model and collected biological samples and histological data from these animals.

Key Insights and Ideas

  • Long-Term Hcy Induces Metabolic Syndrome-like Features: The methionine-fed rats developed a constellation of metabolic disturbances, including elevated fasting blood glucose, increased triglycerides and total cholesterol, and reduced antioxidant capacity (lower SOD, higher MDA). This strongly suggests that chronic hyperhomocysteinemia can drive metabolic dysregulation.
  • Vascular Remodeling is a Consequence of Chronic Hcy: The study provides clear histological evidence of vascular remodeling in both carotid arteries and coronary arterioles. This remodeling was characterized by increased collagen deposition and thickened vessel walls, indicating structural changes that could impair vascular function.
  • PPARγ Downregulation is Linked to Vascular Damage: A critical finding is the significantly decreased expression of PPARγ in the coronary arterioles of the Met group. Given PPARγ's known anti-inflammatory and antioxidant roles, its downregulation likely contributes to the observed vascular damage and metabolic disturbances.
  • Oxidative Stress and NO Dysfunction are Central: The elevated MDA and reduced SOD levels point to significant oxidative stress. This, coupled with decreased NO bioavailability, is hypothesized to be a major driver of endothelial dysfunction and subsequent vascular remodeling.

Key Results

  • Plasma Homocysteine: Significantly elevated in the Met-diet group compared to controls after 48 weeks.
  • Metabolic Parameters:
    • Fasting blood glucose: Increased in the Met group (4.93 ± 0.08 mmol/L vs. 4.23 ± 0.08 mmol/L).
  • Serum triglycerides: Increased in the Met group (0.71 ± 0.03 mmol/L vs. 0.29 ± 0.02 mmol/L).
  • Serum total cholesterol: Increased in the Met group (1.81 ± 0.04 mmol/L vs. 1.37 ± 0.08 mmol/L).
  • Serum MDA: Significantly increased in the Met group (137.18 ± 16.01 µmol/L vs. 27.05 ± 4.51 µmol/L).
  • Serum SOD: Significantly decreased in the Met group (20.31 ± 1.78 U/mL vs. 71.74 ± 1.64 U/mL).
  • Serum NO: Significantly decreased in the Met group (8.22 ± 1.16 µmol/L vs. 22.46 ± 1.05 µmol/L).
  • Vascular Remodeling:
    • Carotid arteries: Showed significantly higher collagen content in the Met group.
  • Coronary arterioles: Exhibited increased wall thickness, higher wall-to-lumen ratios, and increased collagen deposition in the Met group.
  • PPARγ Expression: Significantly decreased in the coronary arterioles of the Met-diet group.

Limitations and Future Work

The authors acknowledge several limitations:

  • Lack of Direct Measurement in Vessels: Markers of oxidative stress (MDA, SOD) and matrix metalloproteinases (MMPs) were not directly measured in the carotid and coronary arteries themselves, only in serum.
  • Unclear Mechanisms: While several factors are implicated, the precise interplay and mechanisms driving vascular remodeling remain to be fully elucidated.

Future research directions suggested by the study include:

  • Elucidating Underlying Mechanisms: Further studies are needed to precisely map the molecular pathways connecting hyperhomocysteinemia, oxidative stress, endothelial dysfunction, PPARγ downregulation, and vascular remodeling.
  • Therapeutic Potential: The findings suggest that targeting PPARγ, potentially with agonists, could be a promising therapeutic strategy for reversing or mitigating Hcy-induced vascular remodeling in patients with hyperhomocysteinemia and metabolic syndrome.
  • Investigating MMPs: Exploring the role of MMPs in Hcy-mediated collagen deposition and ECM degradation warrants further investigation.

Summary updated

Abstract

Hyperhomocysteinemia, a risk factor for vascular disease, is associated with metabolic syndrome. Our study was aimed at exploring the effect of long-term hyperhomocysteinemia with metabolic disturbances on vascular remodeling. We also studied oxidative stress and expression of PPAR<i>γ</i> in the coronary arteriole as a possible mechanism underlying vascular remodeling. Rats were treated with standard rodent chow (Control) or diet enriched in methionine (Met) for 48 weeks. Plasma homocysteine, blood glucose, serum lipids, malondialdehyde (MDA), superoxide dismutase (SOD), and nitric oxide (NO) levels were measured. Coronary arteriolar and carotid arterial remodeling was assessed by histomorphometric techniques and the expression of PPAR<i>γ</i> in vessel wall was investigated. In Met group, an increase in the level of fasting blood glucose, serum triglyceride, total cholesterol, MDA, and NO, a decline in the serum SOD level, and increased collagen deposition in coronary and carotid arteries were found. Moreover, we detected decreased expression of PPAR<i>γ</i> in the coronary arterioles in Met group. In summary, our study revealed metabolic disturbances in this model of long-term hyperhomocysteinemia together with vascular remodeling and suggested that impaired oxidative stress, endothelium dysfunction, and decreased PPAR<i>γ</i> expression in the vessel wall could be underlying mechanisms.
BibTeX
@inproceedings{huo2018vascular,
  author = {Yajing Huo and Xuqing Wu and Jing Ding and Geng Yang and Weiwei Qiao and Anyan Ge and Cen Guo and Jianing Lv and Haifeng Bao and Wei Fan},
  title = {{Vascular Remodeling, Oxidative Stress, and Disrupted PPAR<i>γ</i>Expression in Rats of Long-Term Hyperhomocysteinemia with Metabolic Disturbance}},
  booktitle = {PPAR},
  year = {2018},
  doi = {10.1155/2018/6738703},
}
Figure